期刊文献+

慢性下肢缺血旁路术后早期再狭窄相关因素的研究 被引量:1

Analysis of relative factors of restenosis after artificially grafting bypasses on chronic ischemia of lower extremities
原文传递
导出
摘要 目的探讨慢性下肢缺血行人工血管旁路术后早期发生再狭窄的相关因素。方法回顾性分析2006年1月至2007年9月40例行单侧股胭动脉人工血管旁路术的慢性下肢缺血患者,其中男性36例,女性4例,年龄(66±9)岁。于术前、术后2周行血脂、纤维蛋白原及超敏C反应蛋白检测,术后6个月根据吻合口再狭窄程度分为轻、中、重度狭窄组,分析三组间伴随疾病、高危因素,比较3组血脂、纤维蛋白原、超敏c反应蛋白、同型半胱氨酸、IL-6及转化生长因子β1水平。结果糖尿病和吸烟的患者旁路术后再狭窄程度更严重,相对危险度分别为6.47和7.92。三组术前的各项生化指标差异无统计学意义,术后6个月二组问总胆固醇、低密度脂蛋白、纤维蛋白原、超敏C反应蛋白、IL-6及转化生长因子β1差异有统计学意义。多元线性回归分析示,纤维蛋白原、转化生长因子β1增高与术后内膜增牛程度相关。结论吸烟、伴随糖尿病及纤维蛋白原增高是人工血管旁路术后内膜增生及吻合口再狭窄的临床危险因素。 Objective To analyze the relative factors of early-term restenosis after artificially grafting bypasses on chronic ischemia of lower extremities. Methods From January 2006 to September 2007, 40 cases suffered from chronic ischemia of lower extremities were treated by single side femoropopliteal bypass were followed up during 6 months after operation. There were 36 male and 4 ease female with a mean age of (66±9) years old. Lipid, fibrinogen (FIB) and hypersensitive C reactive protein (hsCRP) were chemical examined during peri-operation. Basing on the degree of restenosis in vascular anastomosis by Color Doppler graft scan, all the patients were derided into light, moderate and severe groups, respectively. Biochemical indictors and cytokines were investigated such as lipid, FIB, hsCRP, IL-6, transforming growing factor betal (TGF-β1) . Possible risk factors resulting in restenosis were compared statistically among three groups with SPSS 15. 0. Results Restenosis were more severe among the patients with concomitance disease such as diabetes mellitus and smoking after operation. Relative risk were 6.47 and 7.92, respectively. There are significant difference in total cholesterin, low density lipoprotein, FIB, hsCRP, IL-6 and TGF-β1 among three groups during six months after operation (P 〈 0. 05). Multiple linear regression showed that FIB and TGF-β1 may be the risk factors to intimal hyperplasia. Conclusion Diabetes mellitus, smoking and higher levels of FIB may be the major high risk factors resulting in neointima hyperplasia and anastomosis restenosis.
出处 《中华外科杂志》 CAS CSCD 北大核心 2009年第22期1698-1701,共4页 Chinese Journal of Surgery
关键词 动脉闭塞性疾病 移植物闭塞 血管 纤维蛋白原 转化生长因子Β1 Arterial occlusive diseases Graft occlusion, vascular Fibrinogen Transforming growth factor betal
  • 相关文献

参考文献13

  • 1Sottiurai VS, Yao JS, Batson RC, et al. Distal anastomotic intimal hyperplasia: histopathologic character and biogenesis. Ann Vasc Surg, 1989,3:26-33.
  • 2Ouriel K. Peripheral arterial disease. Lancet, 2001,358: 1257- 1264.
  • 3Smith I, Franks PJ, Greenhalgh RM, et al. The influence of smoking cessation and hypertriglyceridaemia on the progression of peripheral arterial disease and the onset of critical ischaemia. Eur J Vasc Endovasc Surg, 1996,11:402-408.
  • 4Willigendael EM, Teijink JA, Bartelink ML, et al. Smoking and the patency of lower extremity bypass grafts: a meta-analysis. J Vasc Surg, 2005,42 : 67 -74.
  • 5van der Feen C, Neijens FS, Kanters SD, et al. Angiographic distribution of lower extremity atherosclerosis in patients with and without diabetes. Diabet Med ,2002,19 : 366-370.
  • 6Jude EB, Oyibo SO, Chalmers N, et al. Peripheral arterial disease in diabetic and nondiabetic patients : a comparison of severity and outcome. Diabetes Care ,2001,24 : 1433-1437.
  • 7Osende JI, Badimon JJ, Fuster V, et al. Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control. J Am Coll Cardiol,2001,38 :1307-1312.
  • 8吴杰,戴燕芳,吴洪飞,李斌,陈桂林,夏银燕.血浆纤维蛋白原与血浆粘度相关性及其临床意义研究[J].苏州医学院学报,2000,20(1):54-56. 被引量:8
  • 9王雪青.纤维蛋白(原)在动脉粥样硬化发病中的作用及机制[J].生理科学进展,1996,27(3):245-248. 被引量:41
  • 10Montalescot G, Ankri A, Vicaut E, et al. Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation, 1995,92:31- 38.

二级参考文献23

共引文献46

同被引文献8

  • 1安维洲,董砚虎.他汀类药物的非调脂作用研究现状[J].国际内分泌代谢杂志,2006,26(2):90-92. 被引量:7
  • 2郭伟,符伟国主译.血管和腔内血管外科学精要[M].天津:天津科技翻译出版公司,2010:455.
  • 3Takagi H,Goto SN,Matsui M,et al.A contemporary meta-analysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting[J].J Vasc Surg,2010,52(1):232-236.
  • 4Fatourou EM,Paraskevas KI,Seifalian AM,et al.The role of established and emerging risk factors in peripheral vascular graft occlusion[J].Expert Opin Pharmaeother,2007,8(7):901-911.
  • 5Daskalopoulou SS,Daskalopoulos ME,Mikhailidis DP,et al.Lipid management and peripheral arterial disease[J].Curr Drug Targets,2007,8(4):561-570.
  • 6张纪蔚.股腘小腿动脉阻塞性疾病[M]//汪忠稿,王深明,俞恒锡,等.血管淋巴管外科学.北京:人民卫生出版社,2008:116-170.
  • 7Desai ND,Naylor CD,Kiss A,et al.Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency:insight from a randomized trial[J].Circulation,2007,115(6):678-680.
  • 8赵克强,张小明,沈晨阳,万峰.慢性下肢缺血搭桥术后再狭窄分析[J].中华普通外科杂志,2008,23(4):279-281. 被引量:2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部